Use of Recombinant Factor VII as a Prophylactic Therapy for Adolescent Females With Heavy Menstrual Bleeding

NCT06258980 · clinicaltrials.gov ↗

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Assessing the Bleeding Profile and the Quality of Life of the Enrolled Patients Before and 1 Year After Drug Intervention

Interventions

DRUG: Proph7

Sponsor

Minia University Hospital